Showing papers by "Conor L. Evans published in 2001"

TL;DR: Because photodynamic therapy with verteporfin can safely increase the chance of stabilizing or improving vision in patients with subfoveal CNV from pathologic myopia compared with a placebo, it is recommended ophthalmologists consider vertEPorfin therapy for treatment of such patients.